Galena Biopharma Participates in Two Upcoming Conferences

Galena Biopharma, Inc.

PORTLAND, Ore., March 20, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark W. Schwartz, Ph.D., Executive Vice President and Chief Operating Officer will participate in the following events next week in New York, NY:

  • Thursday, March 27th - Panel presentation and corporate update at the 4th Annual "Cancer Immunotherapy: A Long- Awaited Reality" Conference at the New York Academy of Medicine
  • Friday, March 28th - Corporate presentation at the 21st Annual Future Leaders in the Biotech Industry Conference at the Millennium Broadway Hotel & Conference Center

The corporate presentation will be webcast and available on the Investors section of the Company's website at www.galenabiopharma.com.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit: www.galenabiopharma.com.

CONTACT: Remy Bernarda Vice President, Marketing & Communications (503) 405-8258 rbernarda@galenabiopharma.com

Source:Galena Biopharma